注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
金斯瑞生物科技股份有限公司是一家主要从事生物科学研究及相关业务的香港投资控股公司。该公司通过四大分部运营。生命科学研究服务分部包括基因及多肽合成、脱氧核糖核酸及核酸引物合成、脱氧核糖核酸测序、定制抗体服务、蛋白质表达及稳定细胞株生产。临床前药物研发服务分部包括蛋白及抗体工程、体外药效研究及体内药效研究。生命科学研究目录产品分部提供抗体、重组蛋白、蛋白分离及分析仪器、分子生物学试剂、多肽、生物化学产品及稳定细胞株。工业合成生物产品分部开发及生产工业用酶。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Luquan Wang | 53 | 2015 | Non-Executive Director |
Zumian Dai | 45 | 2015 | Independent Non-Executive Director |
Hong Xin Guo | 59 | 2015 | Independent Non-Executive Director |
Yuexin Pan | 64 | 2015 | Non-Executive Director |
Ye Wang | 55 | 2002 | Co-Founder, President & Executive Director |
Jiange Meng | 55 | 2010 | Executive Chairman |
Li Zhu | 73 | 2010 | Chief Strategy Officer & Executive Director |
Fangliang Zhang | 58 | 2022 | Executive Director |
Jiuan Pan | 56 | 2018 | Independent Non-Executive Director |
Jiafen Wang | 73 | 2018 | Non-Executive Director |
Xuehai Wang | 49 | 2020 | Independent Non-Executive Director |
George McDonald Church | 70 | 2019 | Member of Advisory Board |
David R. Liu | - | 2024 | Member of Scientific Advisory Board |
Carl H. June | 70 | 2024 | Member of Advisory Board |
Chenyang Shi | 56 | 2024 | Independent Non-Executive Director |
Yiu Leung Cheung | 64 | 2024 | Independent Non-Executive Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核